Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational Study.
Kerber R, Lorenz E, Duraffour S, Sissoko D, Rudolf M, Jaeger A, Cisse SD, Camara AM, Miranda O, Castro CM, Akoi Bore J, Raymond Koundouno F, Repits J, Afrough B, Becker-Ziaja B, Hinzmann J, Mertens M, Vitoriano I, Hugh Logue C, Böttcher JP, Pallasch E, Sachse A, Bah A, Cabeza-Cabrerizo M, Nitzsche K, Kuisma E, Michel J, Holm T, Zekeng EG, Cowley LA, Garcia-Dorival I, Hetzelt N, Baum JHJ, Portmann J, Carter L, Yenamaberhan RL, Camino A, Enkirch T, Singethan K, Meisel S, Mazzarelli A, Kosgei A, Kafetzopoulou L, Rickett NY, Patrono LV, Ghebreghiorghis L, Arnold U, Colin G, Juchet S, Marchal CL, Kolie JS, Beavogui AH, Wurr S, Bockholt S, Krumkamp R, May J, Stoecker K, Fleischmann E, Ippolito G, Carroll MW, Koivogui L, Magassouba N, Keita S, Gurry C, Drury P, Diallo B, Formenty P, Wölfel R, Di Caro A, Gabriel M, Anglaret X, Malvy D, Günther S. Kerber R, et al. Among authors: juchet s. J Infect Dis. 2019 Jun 19;220(2):195-202. doi: 10.1093/infdis/jiz078. J Infect Dis. 2019. PMID: 30788508 Free PMC article.
Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern Democratic Republic of the Congo: an emergency use program.
Jaspard M, Juchet S, Serra B, Mayoum B, Kanta IM, Camara MS, Mbala P, Kojan R, Malvy D. Jaspard M, et al. Among authors: juchet s. Int J Infect Dis. 2021 Dec;113:166-167. doi: 10.1016/j.ijid.2021.09.053. Epub 2021 Sep 26. Int J Infect Dis. 2021. PMID: 34587535 Free article.
Clinical presentation, outcomes and factors associated with mortality: A prospective study from three COVID-19 referral care centres in West Africa.
Jaspard M, Sow MS, Juchet S, Dienderé E, Serra B, Kojan R, Sivahera B, Martin C, Kinda M, Lang HJ, Bangaly Sako F, Amara Traoré F, Koumbem E, Tinto H, Sanou A, Sondo A, Kaboré F, Donamou J, Guilavogui JP, Velardo F, Bicaba B, Marcy O, Augier A, Sayadi S, Poda A, Keita S, Anglaret X, Malvy D; COVISTA study group. Jaspard M, et al. Among authors: juchet s. Int J Infect Dis. 2021 Jul;108:45-52. doi: 10.1016/j.ijid.2021.05.024. Epub 2021 May 14. Int J Infect Dis. 2021. PMID: 34000419 Free PMC article.
Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo.
Jaspard M, Mulangu S, Juchet S, Serra B, Dicko I, Lang HJ, Baka BM, Komanda GM, Katsavara JM, Kabuni P, Mambu FM, Isnard M, Vanhecke C, Letord A, Dieye I, Patterson-Lomba O, Mbaya OT, Isekusu F, Mangala D, Biampata JL, Kitenge R, Kinda M, Anglaret X, Muyembe JJ, Kojan R, Ezzedine K, Malvy D. Jaspard M, et al. Among authors: juchet s. EClinicalMedicine. 2022 Oct 13;54:101699. doi: 10.1016/j.eclinm.2022.101699. eCollection 2022 Dec. EClinicalMedicine. 2022. PMID: 36263398 Free PMC article.
Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
Blanc FX, Badje AD, Bonnet M, Gabillard D, Messou E, Muzoora C, Samreth S, Nguyen BD, Borand L, Domergue A, Rapoud D, Natukunda N, Thai S, Juchet S, Eholié SP, Lawn SD, Domoua SK, Anglaret X, Laureillard D; STATIS ANRS 12290 Trial Team. Blanc FX, et al. Among authors: juchet s. N Engl J Med. 2020 Jun 18;382(25):2397-2410. doi: 10.1056/NEJMoa1910708. N Engl J Med. 2020. PMID: 32558469 Clinical Trial.
Improving Ebola virus disease outbreak control through targeted post-exposure prophylaxis.
Hoffmann Dahl E, Mbala P, Juchet S, Touré A, Montoyo A, Serra B, Kojan R, D'Ortenzio E, Blomberg B, Jaspard M. Hoffmann Dahl E, et al. Among authors: juchet s. Lancet Glob Health. 2024 Oct;12(10):e1730-e1736. doi: 10.1016/S2214-109X(24)00255-9. Epub 2024 Sep 10. Lancet Glob Health. 2024. PMID: 39270687 Free article. Review.
Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE).
Duvignaud A, Etafo IC, Jaspard M, Salau Q, Serra B, Kareem AJ, Juchet S, Jegede TO, Gabillard D, Abidoye AT, Le Gal C, Abejegah C, Owhin S, Okwaraeke K, Doutchi M, Katembo Vihundira J, Besong-Lache RM, Seri B, Bérerd-Camara M, Salam APA, Olayinka A, Horby P, Ogbaini-Emovon E, Duraffour S, Ahmed LA, Günther S, Adedosu AN, Anglaret X, Malvy D, Lang HJ, Ayodeji OO. Duvignaud A, et al. Among authors: juchet s. J Pediatric Infect Dis Soc. 2024 Nov 4;13(10):513-522. doi: 10.1093/jpids/piae083. J Pediatric Infect Dis Soc. 2024. PMID: 39167706 Free PMC article.
High Performance of Systematic Combined Urine Liboarabinomannan Test and Sputum Xpert MTB/RIF for Tuberculosis Screening in Severely Immunosuppressed Ambulatory Adults With Human Immunodeficiency Virus.
Bonnet M, Gabillard D, Domoua S, Muzoora C, Messou E, Sovannarith S, Nguyen DB, Badje A, Juchet S, Bunnet D, Borand L, Natukunda N, Tran TH, Anglaret X, Laureillard D, Blanc FX; Systematic empirical vs. Test-guided Anti-tuberculosis Treatment Impact in Severely immunosuppressed HIV-infected adults initiating antiretroviral therapy with CD4 cell counts <100/mm3 (STATIS) Agence Nationale de Recherche sur le Sida et les hépatites virales (ANRS) 12290 Trial Team. Bonnet M, et al. Among authors: juchet s. Clin Infect Dis. 2023 Jul 5;77(1):112-119. doi: 10.1093/cid/ciad125. Clin Infect Dis. 2023. PMID: 36883573
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
PREVAIL II Writing Group; Multi-National PREVAIL II Study Team; Davey RT Jr, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, Beigel J, Tierney J, Lane HC, Fauci AS, Massaquoi MBF, Sahr F, Malvy D. PREVAIL II Writing Group, et al. N Engl J Med. 2016 Oct 13;375(15):1448-1456. doi: 10.1056/NEJMoa1604330. N Engl J Med. 2016. PMID: 27732819 Free PMC article. Clinical Trial.